Epilepsy Awareness Week

May 20th opens the National Epilepsy Week. Epilepsy is one of the most common neurological diseases, and it can affect people of all ages.

However, epileptic seizures can be controlled, and up to 70% of people living with epilepsy could become seizure free via the use of appropriate and affordable anti-seizure medicines. Yet, according to WHO, most of the people with epilepsy living in the middle- and low- income countries do not get the treatment they need.

GCT has conducted a number of clinical trials in Epilepsy: both adult and pediatric population. Please contact us at bd@gctrials.com for more information about our experience and services.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.